89bio Historical Balance Sheet

ETNB Stock

USD 9.59 0.38 4.13%

Trend analysis of 89bio Inc balance sheet accounts such as Total Current Liabilities of 35.8 M or Total Stockholder Equity of 647.6 M provides information on 89bio's total assets, liabilities, and equity, which is the actual value of 89bio Inc to its prevalent stockholders. By breaking down trends over time using 89bio balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining 89bio Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether 89bio Inc is a good buy for the upcoming year.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About 89bio Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of 89bio Inc at a specified time, usually calculated after every quarter, six months, or one year. 89bio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of 89bio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which 89bio currently owns. An asset can also be divided into two categories, current and non-current.

89bio Balance Sheet Chart

At present, 89bio's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 24.8 M, whereas Net Tangible Assets are forecasted to decline to about 122 M.

Total Assets Other Current Liab Total Current Liabilities Property Plant And Equipment Net

Add Fundamental

Total Assets

Total assets refers to the total amount of 89bio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in 89bio Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on 89bio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of 89bio Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Most accounts from 89bio's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into 89bio Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	11.8M	20.5M	23.6M	24.8M
Total Assets	196.8M	596.3M	685.7M	720.0M

Other Current Liab Total Assets

89bio balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock	Net Working Capital
Total Assets		0.99	0.94	1.0	0.75	0.98	-0.92	-0.94	0.7	0.97	1.0	0.69	0.6	1.0	0.88	0.99	0.48	0.87	0.8	1.0	0.84	1.0	0.98	1.0	0.99	1.0
Other Current Liab	0.99		0.98	0.98	0.74	0.97	-0.88	-0.97	0.78	0.94	0.98	0.64	0.56	0.98	0.93	0.99	0.53	0.9	0.86	0.99	0.89	0.98	0.97	0.99	0.99	0.98
Total Current Liabilities	0.94	0.98		0.93	0.76	0.91	-0.82	-0.98	0.87	0.89	0.93	0.64	0.57	0.94	0.97	0.97	0.51	0.94	0.91	0.97	0.89	0.94	0.91	0.94	0.97	0.94
Total Stockholder Equity	1.0	0.98	0.93		0.76	0.97	-0.94	-0.93	0.69	0.98	0.99	0.71	0.62	1.0	0.87	0.98	0.45	0.87	0.8	0.99	0.81	1.0	0.97	1.0	0.98	1.0
Net Tangible Assets	0.75	0.74	0.76	0.76		0.61	-0.85	-0.82	0.73	0.81	0.7	0.92	0.91	0.74	0.85	0.7	-0.13	0.92	0.86	0.78	0.41	0.76	0.61	0.75	0.73	0.74
Property Plant And Equipment Net	0.98	0.97	0.91	0.97	0.61		-0.86	-0.89	0.64	0.92	0.99	0.55	0.44	0.98	0.8	0.98	0.61	0.77	0.72	0.97	0.89	0.97	1.0	0.98	0.97	0.98
Net Debt	-0.92	-0.88	-0.82	-0.94	-0.85	-0.86		0.86	-0.58	-0.98	-0.91	-0.83	-0.76	-0.92	-0.82	-0.86	-0.2	-0.86	-0.76	-0.91	-0.61	-0.93	-0.86	-0.92	-0.87	-0.93
Retained Earnings	-0.94	-0.97	-0.98	-0.93	-0.82	-0.89	0.86		-0.89	-0.89	-0.92	-0.7	-0.63	-0.93	-0.96	-0.95	-0.41	-0.94	-0.94	-0.96	-0.83	-0.94	-0.89	-0.94	-0.96	-0.93
Accounts Payable	0.7	0.78	0.87	0.69	0.73	0.64	-0.58	-0.89		0.61	0.67	0.57	0.52	0.69	0.89	0.76	0.37	0.85	0.96	0.76	0.74	0.7	0.64	0.7	0.77	0.69
Cash	0.97	0.94	0.89	0.98	0.81	0.92	-0.98	-0.89	0.61		0.96	0.78	0.7	0.97	0.86	0.93	0.33	0.88	0.76	0.96	0.72	0.98	0.92	0.97	0.93	0.97
Non Current Assets Total	1.0	0.98	0.93	0.99	0.7	0.99	-0.91	-0.92	0.67	0.96		0.66	0.57	1.0	0.84	0.99	0.53	0.83	0.77	0.99	0.85	0.99	0.99	1.0	0.98	1.0
Non Currrent Assets Other	0.69	0.64	0.64	0.71	0.92	0.55	-0.83	-0.7	0.57	0.78	0.66		0.98	0.69	0.7	0.63	-0.09	0.8	0.72	0.7	0.34	0.7	0.55	0.69	0.64	0.69
Other Assets	0.6	0.56	0.57	0.62	0.91	0.44	-0.76	-0.63	0.52	0.7	0.57	0.98		0.6	0.66	0.54	-0.21	0.77	0.67	0.62	0.24	0.62	0.44	0.6	0.55	0.6
Cash And Short Term Investments	1.0	0.98	0.94	1.0	0.74	0.98	-0.92	-0.93	0.69	0.97	1.0	0.69	0.6		0.87	0.99	0.48	0.87	0.8	0.99	0.84	1.0	0.98	1.0	0.99	1.0
Common Stock Total Equity	0.88	0.93	0.97	0.87	0.85	0.8	-0.82	-0.96	0.89	0.86	0.84	0.7	0.66	0.87		0.89	0.31	0.99	0.95	0.92	0.77	0.88	0.8	0.88	0.9	0.87
Common Stock Shares Outstanding	0.99	0.99	0.97	0.98	0.7	0.98	-0.86	-0.95	0.76	0.93	0.99	0.63	0.54	0.99	0.89		0.59	0.86	0.82	0.99	0.91	0.98	0.98	0.99	0.99	0.99
Non Current Liabilities Total	0.48	0.53	0.51	0.45	-0.13	0.61	-0.2	-0.41	0.37	0.33	0.53	-0.09	-0.21	0.48	0.31	0.59		0.19	0.27	0.47	0.84	0.45	0.61	0.48	0.52	0.48
Capital Surpluse	0.87	0.9	0.94	0.87	0.92	0.77	-0.86	-0.94	0.85	0.88	0.83	0.8	0.77	0.87	0.99	0.86	0.19		0.94	0.91	0.69	0.88	0.77	0.87	0.88	0.86
Other Current Assets	0.8	0.86	0.91	0.8	0.86	0.72	-0.76	-0.94	0.96	0.76	0.77	0.72	0.67	0.8	0.95	0.82	0.27	0.94		0.85	0.71	0.81	0.72	0.8	0.84	0.79
Other Stockholder Equity	1.0	0.99	0.97	0.99	0.78	0.97	-0.91	-0.96	0.76	0.96	0.99	0.7	0.62	0.99	0.92	0.99	0.47	0.91	0.85		0.85	1.0	0.97	1.0	0.99	0.99
Total Liab	0.84	0.89	0.89	0.81	0.41	0.89	-0.61	-0.83	0.74	0.72	0.85	0.34	0.24	0.84	0.77	0.91	0.84	0.69	0.71	0.85		0.82	0.89	0.84	0.87	0.83
Net Invested Capital	1.0	0.98	0.94	1.0	0.76	0.97	-0.93	-0.94	0.7	0.98	0.99	0.7	0.62	1.0	0.88	0.98	0.45	0.88	0.81	1.0	0.82		0.97	1.0	0.99	1.0
Property Plant And Equipment Gross	0.98	0.97	0.91	0.97	0.61	1.0	-0.86	-0.89	0.64	0.92	0.99	0.55	0.44	0.98	0.8	0.98	0.61	0.77	0.72	0.97	0.89	0.97		0.98	0.97	0.98
Total Current Assets	1.0	0.99	0.94	1.0	0.75	0.98	-0.92	-0.94	0.7	0.97	1.0	0.69	0.6	1.0	0.88	0.99	0.48	0.87	0.8	1.0	0.84	1.0	0.98		0.99	1.0
Capital Stock	0.99	0.99	0.97	0.98	0.73	0.97	-0.87	-0.96	0.77	0.93	0.98	0.64	0.55	0.99	0.9	0.99	0.52	0.88	0.84	0.99	0.87	0.99	0.97	0.99		0.99
Net Working Capital	1.0	0.98	0.94	1.0	0.74	0.98	-0.93	-0.93	0.69	0.97	1.0	0.69	0.6	1.0	0.87	0.99	0.48	0.86	0.79	0.99	0.83	1.0	0.98	1.0	0.99

Click cells to compare fundamentals

89bio Account Relationship Matchups

89bio balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	211.1M	162.4M	196.8M	596.3M	685.7M	720.0M
Other Current Liab	6.0M	10.2M	11.8M	20.5M	23.6M	24.8M
Total Current Liabilities	8.1M	19.5M	24.6M	29.6M	34.1M	35.8M
Total Stockholder Equity	203.0M	126.0M	151.8M	536.3M	616.8M	647.6M
Net Tangible Assets	89.9M	203.0M	126.0M	151.8M	174.6M	122.0M
Property Plant And Equipment Net	166K	150K	455K	2.3M	2.7M	2.8M
Net Debt	(204.7M)	(131.3M)	(35.2M)	(289.1M)	(260.1M)	(247.1M)
Retained Earnings	(123.1M)	(213.2M)	(315.2M)	(457.4M)	(411.7M)	(391.1M)
Accounts Payable	2.1M	6.8M	12.5M	8.6M	9.9M	6.0M
Cash	204.7M	150.7M	55.3M	316.2M	363.6M	381.8M
Non Current Assets Total	872K	440K	744K	2.7M	3.1M	3.3M
Non Currrent Assets Other	706K	290K	289K	396K	455.4K	331.1K
Other Assets	72K	706K	290K	289K	332.4K	302.9K
Cash And Short Term Investments	204.7M	150.7M	188.2M	578.9M	665.7M	699.0M
Common Stock Shares Outstanding	16.1M	20.1M	34.8M	71.2M	81.8M	85.9M
Liabilities And Stockholders Equity	211.1M	162.4M	196.8M	596.3M	685.7M	720.0M
Non Current Liabilities Total	2.1M	16.9M	20.4M	30.4M	34.9M	36.7M
Other Current Assets	5.6M	11.3M	15.8M	14.7M	16.9M	9.1M
Other Stockholder Equity	326.0M	339.2M	467.4M	993.5M	1.1B	1.2B
Total Liab	8.1M	36.5M	45.0M	60.0M	69.0M	72.4M
Net Invested Capital	203.0M	145.4M	171.5M	561.1M	645.3M	677.5M
Property Plant And Equipment Gross	166K	150K	455K	2.3M	2.7M	2.8M
Total Current Assets	210.2M	162.0M	196.1M	593.5M	682.6M	716.7M
Accumulated Other Comprehensive Income	(10K)	(64K)	(350K)	190K	218.5K	229.4K
Net Working Capital	202.1M	142.4M	171.5M	563.9M	648.5M	680.9M
Property Plant Equipment	155K	166K	150K	92K	105.8K	131.1K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

When determining whether 89bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of 89bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of 89bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on 89bio Inc Stock:

How To Invest In 89bio

Details

Is 89bio Stock a good investment?

Details

What is 89bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 89bio. If investors know 89bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 89bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.96)

Return On Assets

(0.41)

Return On Equity

(0.73)

The market value of 89bio Inc is measured differently than its book value, which is the value of 89bio that is recorded on the company's balance sheet. Investors also form their own opinion of 89bio's value that differs from its market value or its book value, called intrinsic value, which is 89bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 89bio's market value can be influenced by many factors that don't directly affect 89bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between 89bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 89bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 89bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

89bio Historical Balance Sheet

About 89bio Balance Sheet Analysis

89bio Balance Sheet Chart

Total Assets

Total Current Liabilities

Property Plant And Equipment Net

89bio balance sheet Correlations

89bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

89bio balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Other Stockholder Equity	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets

Cash	- 0.98	Net Debt
Retained Earnings	- 0.98	Total Current Liabilities
Retained Earnings	- 0.97	Other Current Liab
Capital Stock	- 0.96	Retained Earnings
Other Stockholder Equity	- 0.96	Retained Earnings
Common Stock Total Equity	- 0.96	Retained Earnings